Division of Genomic Medicine BioBank Japan Project for Genomic and Clinical Research
|Key Fields||Japan Genomic Medicine Program(1st)|
In this project, we are aiming to contribute to the achievement of genomic medicine by promoting the effective utilization of samples, clinical information and genome data acquired over years by BioBank Japan (BBJ), one of the largest disease biobanks in the world.
For information on previous project, please refer to the "Tailor-Made Medical Treatment Program" webpage.
Follow these links for further details.
Management and Evaluation Framework
- PS (Program Supervisor)
- KOHSAKA Shinich, M.D., Ph.D., Director-General Emeritus, National Institute of Neuroscience, National Center of Neurology and Psychiatry
- PO (Program Officer)
- ISHIKAWA Shumpei, M.D., Ph.D., Professor, Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo
- KANAI Yae, M.D., Ph.D., Professor, Department of Pathology, Keio University School of Medicine
- NAKAGAWA Hidewaki, M.D., Ph.D., Team Leader, Laboratory for Genome Sequencing Analysis, RIKEN Center for Integrative Medical Sciences
Last updated 11/20/19